A. Lagarde

860 total citations
19 papers, 706 citations indexed

About

A. Lagarde is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, A. Lagarde has authored 19 papers receiving a total of 706 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in A. Lagarde's work include Cancer Research and Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers) and Glycosylation and Glycoproteins Research (2 papers). A. Lagarde is often cited by papers focused on Cancer Research and Treatments (3 papers), Cancer Genomics and Diagnostics (3 papers) and Glycosylation and Glycoproteins Research (2 papers). A. Lagarde collaborates with scholars based in Canada, France and United Kingdom. A. Lagarde's co-authors include Robert S. Kerbel, Jacques Pouysségur, Klaus Seuwen, John Roder, Danuta Kozbor, T. P. Donaghue, James W. Dennis, Carol Waghorne, Kerbel Rs and Bożena Korczak and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and The Journal of Immunology.

In The Last Decade

A. Lagarde

19 papers receiving 649 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lagarde Canada 10 362 255 182 165 138 19 706
Nelson Ellmore United States 9 647 1.8× 359 1.4× 117 0.6× 178 1.1× 93 0.7× 11 1.0k
L. C. Padhy India 6 530 1.5× 490 1.9× 151 0.8× 100 0.6× 267 1.9× 11 890
J Doll United States 6 383 1.1× 395 1.5× 337 1.9× 130 0.8× 92 0.7× 6 856
Shuichi Ikeyama Japan 10 546 1.5× 270 1.1× 191 1.0× 146 0.9× 112 0.8× 13 901
Melissa C Adriance United States 7 472 1.3× 380 1.5× 154 0.8× 150 0.9× 109 0.8× 7 805
L. TOSTO United States 4 544 1.5× 209 0.8× 173 1.0× 106 0.6× 87 0.6× 5 702
Y H Xu United States 5 570 1.6× 343 1.3× 78 0.4× 122 0.7× 155 1.1× 8 863
B Endlich United States 12 642 1.8× 262 1.0× 122 0.7× 66 0.4× 95 0.7× 18 887
David Siwarski United States 17 602 1.7× 442 1.7× 139 0.8× 397 2.4× 84 0.6× 41 1.1k
E Gorelik United States 17 306 0.8× 238 0.9× 114 0.6× 419 2.5× 55 0.4× 27 800

Countries citing papers authored by A. Lagarde

Since Specialization
Citations

This map shows the geographic impact of A. Lagarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lagarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lagarde more than expected).

Fields of papers citing papers by A. Lagarde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lagarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lagarde. The network helps show where A. Lagarde may publish in the future.

Co-authorship network of co-authors of A. Lagarde

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lagarde. A scholar is included among the top collaborators of A. Lagarde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lagarde. A. Lagarde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Lagarde, A., Aline Pinon, Bertrand Liagre, et al.. (2018). Antiproliferative and antibiofilm potentials of endolichenic fungi associated with the lichenNephroma laevigatum. Journal of Applied Microbiology. 126(4). 1044–1058. 8 indexed citations
2.
Lagarde, A., et al.. (2016). Cytotoxic activity of endolichenic fungi isolated from the lichen Nephroma laevigatum. Planta Medica. 81(S 01). S1–S381. 2 indexed citations
3.
Cappelli, Mario, H. Štern, Lauren Humphreys, et al.. (2002). Participation rates of Ashkenazi Jews in a colon cancer community‐based screening/prevention study. Clinical Genetics. 61(2). 104–114. 8 indexed citations
4.
Štern, H. & A. Lagarde. (1998). Genetics of hereditary colon cancer: a model for prevention.. PubMed. 41(5). 345–50. 4 indexed citations
5.
Sadowski, Ivan, Tony Pawson, & A. Lagarde. (1989). v-fps protein-tyrosine kinase coordinately enhances the malignancy and growth factor responsiveness of pre-neoplastic lung fibroblasts. Lung Cancer. 5(3). 15–16. 6 indexed citations
6.
Waghorne, Carol, Michaël Thomas, A. Lagarde, Robert S. Kerbel, & Martin L. Breitman. (1988). Genetic evidence for progressive selection and overgrowth of primary tumors by metastatic cell subpopulations.. PubMed. 48(21). 6109–14. 81 indexed citations
7.
Chadwick, Dianne & A. Lagarde. (1988). Coincidental Acquisition of Growth Autonomy and Metastatic Potential During the Malignant Transformation of Factor-Dependent CCL39 Lung Fibroblasts. JNCI Journal of the National Cancer Institute. 80(5). 318–325. 32 indexed citations
8.
Seuwen, Klaus, A. Lagarde, & Jacques Pouysségur. (1988). Deregulation of hamster fibroblast proliferation by mutated ras oncogenes is not mediated by constitutive activation of phosphoinositide-specific phospholipase C.. The EMBO Journal. 7(1). 161–168. 130 indexed citations
9.
Rs, Kerbel, et al.. (1988). Clonal dominance of primary tumours by metastatic cells: genetic analysis and biological implications.. PubMed. 7(4). 597–629. 83 indexed citations
10.
Miller, Veronica, A. Lagarde, B. Michael Longenecker, & Harry B. Greenberg. (1986). A phenyl-beta-galactoside-specific monoclonal antibody reactive with murine and rat NK cells.. The Journal of Immunology. 136(8). 2968–2974. 20 indexed citations
11.
Pouysségur, Jacques, et al.. (1986). Differential Tumorigenicity of Growth Factor-Dependent Versus-Independent CCL39 Lung Fibroblast Lines in Nude Mice<xref ref-type="fn" rid="FN1">2</xref>. JNCI Journal of the National Cancer Institute. 77(1). 105–14. 9 indexed citations
12.
Lagarde, A. & Robert S. Kerbel. (1985). Somatic cell hybridization in vivo and in vitro in relation to the metastatic phenotype. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 823(2). 81–110. 24 indexed citations
13.
Kerbel, Robert S., A. Lagarde, James W. Dennis, & T. P. Donaghue. (1983). Spontaneous fusion in vivo between normal host and tumor cells: possible contribution to tumor progression and metastasis studied with a lectin-resistant mutant tumor.. Molecular and Cellular Biology. 3(4). 523–538. 112 indexed citations
14.
Lagarde, A., T. P. Donaghue, James W. Dennis, & Robert S. Kerbel. (1983). Genotypic and Phenotypic Evolution of a Murine Tumor During Its Progression In Vivo Toward Metastasis<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 71(1). 183–91. 29 indexed citations
15.
Lagarde, A., et al.. (1982). [Murine cloned cells related to basophil-mast cell granulocytes, spontaneously cytotoxic toward tumor cells].. PubMed. 295(4). 287–92. 1 indexed citations
16.
Kozbor, Danuta, A. Lagarde, & John Roder. (1982). Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.. Proceedings of the National Academy of Sciences. 79(21). 6651–6655. 123 indexed citations
17.
Lagarde, A. & Bruce A. Haddock. (1977). Proton uptake linked to the 3-deoxy-2-oxo-d-gluconate-transport system of Escherichia coli. Biochemical Journal. 162(1). 183–187. 9 indexed citations
18.
Lagarde, A., et al.. (1972). Cyclic 3′,5′-AMP phosphodiesterase of human blood lymphocytes. Biochimica et Biophysica Acta (BBA) - Enzymology. 276(2). 444–453. 24 indexed citations
19.
Lagarde, A., et al.. (1970). [Stimulation of adenyl-cyclase in lysates of human circulating lymphocytes under the influence of phytohemagglutinin or antilymphocyte serum].. PubMed. 271(8). 726–9. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026